Bruce Greenberg
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Bruce Greenberg
The proxy statement of Aldeyra Therapeutics, Inc. reports total compensation of $1,217,546 for Bruce Greenberg in fiscal 2024, including a base salary of $245,099. Disclosed compensation is on record for 3 fiscal years. Bruce Greenberg has spoken on 3 earnings calls across 1 company, most recently for Aldeyra Therapeutics, Inc. on March 9, 2023.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-05-10–present
-
Start not stated–2024-04-22
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aldeyra Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Gary M. Phillips CEO, Board Member
- Neal S. Walker CEO
- Todd C. Brady CEO, Board Member
- William D. Clark CEO, Board Member
- Martin J. Joyce CFO, Board Member
- Michael Alfieri CFO
- Darlene Deptula-Hicks Board Member
- Nancy B. Miller-Rich Board Member
- William (Chip) Clark Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Aldeyra Therapeutics, Inc. (ALDX) | M.B.A. former Senior Vice President of Finance, Interim Chief Financial Officer | $245,099 | $1,217,546 |
| 2023 | Aldeyra Therapeutics, Inc. (ALDX) | M.B.A. former Senior Vice President of Finance, Interim Chief Financial Officer | $330,000 | $974,067 |
| 2022 | Aldeyra Therapeutics, Inc. (ALDX) | M.B.A. Senior Vice President of Finance, Interim Chief Financial Officer | $285,340 | $1,482,055 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.